90 related articles for article (PubMed ID: 1305870)
1. [The effect of bonnecor on blood coagulability and thrombocyte aggregation in transient myocardial ischemia].
Denisova SV; Sapozhkov AV
Eksp Klin Farmakol; 1992; 55(6):29-31. PubMed ID: 1305870
[TBL] [Abstract][Full Text] [Related]
2. [The antifibrillatory properties of bonnecor].
Grigor'eva EK; Gorbunova VV
Farmakol Toksikol; 1990; 53(3):36-7. PubMed ID: 2387377
[TBL] [Abstract][Full Text] [Related]
3. [Bonnecor--a new anti-arrhythmia preparation].
Berdiaev SIu; Lyskovtsev VV; Senova ZP; Darinskiĭ NV; Grigor'eva EK; Tolmacheva EA; Turilova AI; Gritsenko AN; Kaverina NV
Farmakol Toksikol; 1990; 53(3):33-6. PubMed ID: 2387376
[TBL] [Abstract][Full Text] [Related]
4. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
[TBL] [Abstract][Full Text] [Related]
5. [A comparative study of the pharmacokinetics and pharmacodynamics of bonnecor].
Rodionov AP; Lyskovtsev VV; Ignatova NA; Tolmacheva EA; Grigor'eva EK; Belinskiaia GF; Sheĭnberg BV
Farmakol Toksikol; 1990; 53(3):40-3. PubMed ID: 1696909
[TBL] [Abstract][Full Text] [Related]
6. [A comparative study of the antiarrhythmic action of bonnecor and the mesidide derivatives of alpha-azacycloalkane carboxylic acids].
Paliani-Katsitadze NSh; Berdiaev SIu; Turilova AI; Kaverina NV; Likhosherstov AM
Eksp Klin Farmakol; 1994; 57(3):15-7. PubMed ID: 8049618
[TBL] [Abstract][Full Text] [Related]
7. [An experimental study of the safety of the preparation bonnecor in trials on dogs].
Kovalenko LP; Sorokina AV; Popova GR; Batanova OA; Liubimov BI
Farmakol Toksikol; 1990; 53(3):54-7. PubMed ID: 2387384
[TBL] [Abstract][Full Text] [Related]
8. [The pharmacodynamics of the new anti-arrhythmia preparation bonnecor in patients with extrasystoles].
Ol'binskaia LI; Rybakov MA; Sizova ZhM
Farmakol Toksikol; 1990; 53(3):63-4. PubMed ID: 1696910
[TBL] [Abstract][Full Text] [Related]
9. [The effect of bonnecor on cardiac hemodynamics, blood supply and function in experimental myocardial ischemia].
Chichkanov GG; Tolmacheva EA; Lyskovtsev VV; Grigor'eva EK; Matsievskiĭ DD
Farmakol Toksikol; 1990; 53(3):38-40. PubMed ID: 2387378
[TBL] [Abstract][Full Text] [Related]
10. [The anti-arrhythmia properties of bonnecor metabolites].
Grigor'eva EK; Poppe H; Tolmacheva EA; Krasnykh LM
Farmakol Toksikol; 1990; 53(3):48-50. PubMed ID: 2387382
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological research on bonnecor and its metabolites].
Poppe H; Heer S; Barch R
Farmakol Toksikol; 1990; 53(3):46-8. PubMed ID: 2387381
[TBL] [Abstract][Full Text] [Related]
12. [Anti-arrhythmia and antifibrillatory properties of dibenzazepine derivatives].
Senova ZP; Lyskovtsev VV; Grigor'eva EK; Gorbunova VV; Kaverina NV
Kardiologiia; 1986 Aug; 26(8):24-8. PubMed ID: 3761845
[TBL] [Abstract][Full Text] [Related]
13. [The relationship between the chemical structure and anti-arrhythmia action of a number of omega-aminoacyl-3-carbalcoxyaminodibenzazepines].
Gritsenko AN; Lyskovtsev VV; Senova ZP; Skoldinov AP; Stark A; Wunderlich G; Poppe H; Barch R
Farmakol Toksikol; 1990; 53(3):30-2. PubMed ID: 2387375
[TBL] [Abstract][Full Text] [Related]
14. [Electrophysiologic research on the anti-arrhythmia properties of bonnecor--a new dibenzazepine derivative].
Berdiaev SIu; Marko R; Kelemen K; Darinskiĭ NV; Kaverina NV
Kardiologiia; 1986 Aug; 26(8):16-9. PubMed ID: 3531669
[TBL] [Abstract][Full Text] [Related]
15. [Effect of xanthine derivatives on thrombocyte aggregation and other hemostatic indices].
Lakin KM; Ovnatanova MS; Matiashova MA; Mashkovskiĭ MD
Biull Eksp Biol Med; 1980 Feb; 89(2):181-2. PubMed ID: 7370418
[TBL] [Abstract][Full Text] [Related]
16. [Effect of etmozin on thrombocyte aggregation capacity].
Dariskiĭ NV; Turilova AI; Korbut R; Marchenkevich E
Biull Eksp Biol Med; 1982 May; 93(5):74-6. PubMed ID: 6807371
[TBL] [Abstract][Full Text] [Related]
17. [Effect of the new anti-arrhythmia preparation Bonnecor on the hemodynamics and activity of the ischemic heart].
Tolmacheva EA; Chichkanov GG; Matsievskiĭ DD
Biull Eksp Biol Med; 1989 May; 107(5):588-90. PubMed ID: 2736295
[TBL] [Abstract][Full Text] [Related]
18. [The pharmacodynamics and pharmacokinetics of bonnecor in patients with different disorders of the heart rhythm].
Lozinskiĭ LG; Zamotaev IP; Zeltyn'-Abramov EM; Orlov VA; Beloborodov VL; Kosilova EE; Zalesskaia MA; Tiukavkina NA
Farmakol Toksikol; 1990; 53(3):61-3. PubMed ID: 2387386
[TBL] [Abstract][Full Text] [Related]
19. [The anti-arrhythmia action of tiracizine in patients with ischemic heart disease and decreased myocardial contractile function].
Mishin IuI; Kliachkina IL; Ivashkin VT; Min'kova TI; Bannikova SD
Voen Med Zh; 1997 Jun; 318(6):44-7. PubMed ID: 9412062
[No Abstract] [Full Text] [Related]
20. [Use of bonnecor in ischemic heart disease].
Gorshkov VA; Nesvetov VN; Chestukhin VV; Narynskiĭ AK; Kesarev GV; Solov'eva FV; Orlov VN; Ianitskaia MV; Solodukhina IS
Sov Med; 1990; (6):72-4. PubMed ID: 2396129
[No Abstract] [Full Text] [Related]
[Next] [New Search]
